My narrative is now published in @JCOGO_ASCO.
A reflection on a clinical encounter during my residency that reshaped how I understand the emotional and financial burden patients carry through cancer care.
🔗https://t.co/vcoRlqzQd8
#FinTox#GlobalOncology#CancerDisparities
“When Less Is Truly More”
Excited to share our work from Med Onc @OffCMCVellore published in @JCOGO_ASCO
"Does adding low dose Nivo to NACT ⬆️response rates & survival in stage III non-oncogene-driven NSCLC?"
🔗https://t.co/6cMfz2o2Cq
Mentor @todrashish
Key findings👇🧵#LCSM
Locally advanced, high risk low rectal cancer is difficult to treat..glad to share our outcomes with escalated treatment intensity by Induction combination chemotherapy followed by uninterrupted full dose chemotherapy along with long course radiotherapy
https://t.co/RxP3H2LyOv
nature has actually contacted me for comment about accusations that Sci-Hub is a threat, here is my full response / it is clear that academic publishers care about their money, not about security of other people
Posted as received: This poignant photo is the work of an Afghan artist named Shamsia Hassani, 33 years old, Afghan graffiti artist and teacher at Kabul University If we share, we will be giving her a voice and all Afghan women who are living in hell.
I wonder if patients know that their #oncologists also get #scanxiety the day before follow up clinic? We are also desperate to know if you responded to treatment, if you’re in remission, or if we need to have the difficult conversation about what comes next.
Wow - impressive EFS benefit of adding carboplatin to NACT for TNBC in #BrighTNess trial!
👉4-year EFS was 79% with carbo vs 68% w/o (HR 0.57, p=0.02)
Just released by @myESMO Daily Reporter, these data will be presented by S.Loibl on 17 Sept @ #ESMO21
https://t.co/lU7ADqw2VQ
I couldn't believe my eyes. So I asked my colleague to read to me the recent Covid19 guidelines by DGHS @MoHFW_INDIA. I couldn't believe my ears too.
The 9-page-PDF guides how to treat, investigate and monitor patients with Covid19 infection.
What is the first surprise? 1/N
https://t.co/dozqsU0ecj
Even before we begin using CPI for eTNBC in resource limited settings.. GeparNUEVO questions the science behind the use and duration of post operative adjuvant CPI treatment in eTNBC..
#ASCO2021#Oncoalert
Here’s to the women who have taken over the world. What keeps their spirit unwavered? Being a rebel. It's time to let the rebel in you take over 🔥
#TRebelWithboAt#IAmARebel
@ahmermkhan Wonder what everyone will say once there s a new breakout... they won't blame the religion(of majority) or the govt..
( unlike tabligi meeting ...)
well.. we probably just have to take it hands down..and deal with the aftermath.. just as tolerant indians.